MedPath

A One Day Expedited Treatment for Adults with Anxiety Disorders

Not Applicable
Recruiting
Conditions
anxiety disorders
Mental Health - Anxiety
Registration Number
ACTRN12623000615684
Lead Sponsor
niversity of Technology Sydney
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
25
Inclusion Criteria

(1) Australian resident;
(2) 18-years-of-age or above;
(3) Able to read and write English;
(4) Meet criteria for an anxiety disorder as their primary mental health condition on the Diagnostic Interview for Anxiety, Mood, Obsessive-Compulsive and other Neuropsychiatric Disorders (DIAMOND);
(5) Medication free or on a stable dose of psychotropic medication for at least 8 weeks, and;
(6) Not currently receiving regular psychological services for their anxiety disorder (i.e., those seeing their clinician once a week or more will be excluded).

Exclusion Criteria

(1) Severe depressive symptoms as assessed by a score of 20 or above on the PHQ-9;
(2) Suicide risk as assessed by a score of ‘2’ (more than half the days) or higher on item 9 of the PHQ-9 on the screening questions or via clinician judgement during the diagnostic interview using the C-SSRS;
(3) Daily alcohol use or daily illicit drug use;
(4) The presence of a schizophrenia spectrum disorder as assessed by the DIAMOND;
(5) Significant cognitive/intellectual impairment as assessed during the diagnostic interview;
(6) A medical condition that may interfere with treatment as indicated on the demographic questionnaire.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Overall Anxiety Severity and Impairment Scale (OASIS) [ Pre-treatment<br>Post-treatment (primary end-point) (within one-week post-treatment)<br>1-month follow up<br>3-month follow up];Clinical Global Impression (CGI) scale (measuring overall severity of anxiety symptoms)[ Pre-treatment<br>Post-treatment (primary end-point) (within one-week post-treatment)<br>1-month follow up<br>3-month follow up];Client Satisfaction Questionnaire (CSQ) [ Post-treatment (within one-week post-treatment)]
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath